125
Participants
Start Date
January 5, 2016
Primary Completion Date
January 15, 2018
Study Completion Date
January 15, 2018
Dapagliflozin
Subject who will be randomized to the 'Dapagliflozin arm' will be treated with dapagliflozin 10mg + Metformin 1000 mg as Diabetes Treatment
Glimepiride
Subject who will be randomized to the 'Glimepiride arm' will be treated with glimepiride 1-2mg + Metformin 1000 mg as Diabetes Treatment
Research Site, Goyang-si
Research Site, Uijeongbu-si
Research Site, Seongnam-si
Research Site, Ansan-si
Research Site, Suwon
Research Site, Incheon
Research Site, Daejeon
Research Site, Daegu
Research Site, Changwon-si
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Wŏnju
Lead Sponsor
AstraZeneca
INDUSTRY